A review of ligand tethered surface engineered carbon nanotubes

Biomaterials

Volumn 35, Issue 4, 2014, Pages 1267-1283

  Mehra, Neelesh Kumar ^a   Mishra, Vijay ^a   Jain, N K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Carbon nanotubes; Conjugation chemistry; Functionalization; Ligand tethered; Safety and efficacy

Indexed keywords

BIOMEDICAL APPLICATIONS; CONJUGATION CHEMISTRY; FUNCTIONALIZATIONS; HIGH SURFACE AREA; MEMBRANE PENETRATION; PHOTOLUMINESCENCE PROPERTIES; PHYSICOCHEMICAL PROPERTY; TARGETING LIGANDS;

AMINO ACIDS; BIOCOMPATIBILITY; CARBON NANOTUBES; CELL MEMBRANES; CYTOLOGY; LIGANDS; MEDICAL APPLICATIONS; MONOCLONAL ANTIBODIES; NUCLEIC ACIDS; PROTEINS; SURFACES;

BIOMOLECULES;

AMINO ACID; ANIOPEP 2; APTAMER; ARGINYLGLYCYLASPARTIC ACID; ASPARAGINYLGLYCYLARGININE; BIOPOLYMER; CARBON NANOTUBE; DNA; DOUBLE WALLED NANOTUBE; ENZYME; LIGAND; MONOCLONAL ANTIBODY; MULTI WALLED NANOTUBE; NANOMATERIAL; NANOPARTICLE; PROTEIN DERIVATIVE; SINGLE WALLED NANOTUBE; SMALL INTERFERING RNA; SURFACTANT; TRIPLE WALLED CARBON NANOTUBE; UNCLASSIFIED DRUG; VITAMIN;

BIOCOMPATIBILITY; CELL MEMBRANE PERMEABILITY; CONJUGATION; HYDROPHILICITY; PHOTOLUMINESCENCE; PRIORITY JOURNAL; REVIEW; SAFETY; SURFACE PROPERTY;

CARBON NANOTUBES; CONJUGATION CHEMISTRY; FUNCTIONALIZATION; LIGAND TETHERED; SAFETY AND EFFICACY;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; LIGANDS; MODELS, MOLECULAR; NANOTECHNOLOGY; NANOTUBES, CARBON; SURFACE PROPERTIES;

EID: 84888433368     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.032     Document Type: Review

References (142)

1. Zhang Y., Bai Y., Yan B. Functionalized carbon nanotubes for potential medicinal applications. Drug Discov Today 2010, 15(11/12):428-435.
2. [accessed 14.04.13]. http://www.prweb.com/releases/nanotechnology_nanotubes/nanomaterials_nanofilms/prweb9120599.htm.
3. Mousa S.A., Bharali D.J. Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applications. Cancer 2011, 3:2888-2903.
4. Mehra N.K., Mishra V., Jain N.K. Receptor based therapeutic targeting. Ther Deliv 2013, 4(3):369-394.
5. Jain N.K., Mishra V., Mehra N.K. Targeted drug delivery to macrophages. Expert Opin Drug Deliv 2013, 10(3):353-367.
6. Mehra N.K., Jain A.K., Lodhi N., Dubey V., Mishra D., Raj R., et al. Challenges in the use of carbon nanotubes for biomedical application. Crit Rev Ther Drug Carrier Syst 2008, 25(2):169-206.
7. Jain A.K., Mehra N.K., Lodhi N., Dubey V., Mishra D., Jain N.K. Carbon nanotubes and their toxicity. Nanotoxicol 2007, 1(3):167-197.
8. Koo O.M., Rubinstein I., Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005, 1:193-212.
9. Agrawal U., Mehra N.K., Gupta U., Jain N.K. Hyperbranched dendritic nano-carriers for topical delivery of dithranol. JDrug Target 2013, 21(5):497-506.
10. Gajbhiye V., Ganesh N., Barve J., Jain N.K. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly (propylene imine) dendrimers. Eur J Pharm Sci 2013, 48:668-679.
11. Jain K., Kesharwani P., Gupta U., Jain N.K. Areview of glycosylated carriers for drug delivery. Biomaterials 2012, 33(16):4166-4186.
12. Mishra V., Gupta U., Jain N.K. Influence of different generations of poly (propylene imine) dendrimers on human erythrocytes. Pharmazie 2010, 65:891-895.
13. Mishra V., Gupta U., Jain N.K. Surface-engineered dendrimers: a solution for toxicity issues. JBiomat Sci Polym Ed 2009, 20:141-166.
14. Jain A., Mehra N.K., Nahar M., Jain N.K. Topical delivery of enoxaparin using nanostructured lipid carrier. JMicroencapsul 2013, 30(7):709-715.
15. Mehra N.K., Jain N.K. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes. JDrug Target 2013, 21(8):745-758.
16. Lodhi N., Mehra N.K., Jain N.K. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. JDrug Target 2013, 21(1):67-76.
17. Singh R., Mehra N.K., Jain V., Jain N.K. Folic acid conjugated carbon nanotubes for gemcitabine HCL delivery. JDrug Target 2013, 21(6):581-592.
18. Ren J., Shen S., Wang D., Xi Z., Guo L., Pang Z., et al. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 2012, 33:3324-3333.
19. Lacerda L., Ali-Boucetta H., Herrero M., Pastorin G., Bianco A., Prato M., et al. Tissue histology and physiology following intravenous administration of different types functionalized multiwalled carbon nanotubes. Nanomedicine 2008, 3:149-161.
20. Lacerda L., Russier J., Pastorin G., Herrero M.A., Venturelli E., Dumortier H., et al. Translocation mechanisms of chemically functionalized carbon nanotubes across plasma membranes. Biomaterials 2012, 33:3334-3343.
21. Meng L., Zhang X., Lu Q., Fei Z., Dyson P.J. Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. Biomaterials 2012, 33:1689-1698.
22. Pruthi J., Mehra N.K., Jain N.K. Macrophages targeting of amphotericin B through mannosylated multi walled carbon nanotubes. JDrug Target 2012, 20(7):593-604.
23. Kayat J., Gajbhiye V., Tekade R.K., Jain N.K. Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomedicine 2011, 7(1):40-49.
24. Zhang X., Meng L., Lu Q., Fei Z., Dyson P.J. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 2009, 30:6041-6047.
25. Hirsch A. Functionalization of single-walled carbon nanotubes. Angew Chem Int Ed 2002, 41(11):1853-1859.
26. Steichen S.D., Caldorera-Moore M., Peppas N.A. Areview of current nanoparticles and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 2013, 48:416-427.
27. Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354:56-58.
28. Bacon R. Filamentary graphite and method for producing the same. US Patent. 2957756 1960; Issued October 25.
29. Bacon R. Growth, structure and properties of graphite whiskers. JAppl Phys 1960, 31(2):283-290.
30. Radushkevich L.V., Lukyanovich V.M.O. Structure ugleroda, obrazujucegosja pri termiceskom ra-zlozenii okisi ugleroda na zeleznom kontakte. Zurn Fis Chim 1952, 26:88-95. [in Russian].
31. Oberlin A., Endo M. Filamentous growth of carbon through benzene decomposition. JCryst Growth 1976, 32(3):335-349.
32. Izvestiya Akademii Nauk SSSR Metals 1982, 3:12-17. [in Russian].
33. Tennent H.G. Carbon fibrils, method for producing same and composition containing same 1987-05-05, US 4663230.
34. Dresselhaus M.S., Dresselhaus G., Eklund P.C. Science of fullerenes and carbon nanotubes 1995, 117:129. Academic, San Diego.
35. Abrahamson J., Wiles P.G., Rhoades B.L. Structure of carbon fibres found on carbon arc anodes. Carbon 1999, 37(11):1873.
36. Iijima S., Ichihashi T. Single-shell carbon nanotubes of 1-nm diameter. Nature 1993, 363:603-605.
37. Bethune D.S., Klang C.H., Vries M.S.D., Gorman G., Savoy R., Vazquez J., et al. Cobalt-catalysed growth of carbon nanotubes with single-atomic layer walls. Nature 1993, 363:605-607.
38. Monthioux M., Kuznetsov V.L. Who should be given credit for the discovery of carbon nanotubes. Carbon 2006, 44:1621-1625.
39. Monthioux M., Flahaut E., Razafinimanana M., Lauraent C., Peigney A., Bacsa W., et al. Introduction to carbon nanotubes. Handbook of nanotechnology 2007, 43-112. Springer.
40. Li R., Wu R., Zhao L., Hu Z., Guo S., Pan X., et al. Folate and iron difunctionalized multiwall carbon nanotubes as dual-targeted drug nanocarrier to cancer cells. Carbon 2011, 49(5):1797-1805.
41. Kostarelos K., Bianco A., Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 2009, 4:627-633.
42. Kam N.W.S., Liu Z., Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. JAm Chem Soc 2005, 127:12492-12493.
43. Kam N.W.S., Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. JAm Chem Soc 2005, 127(16):6021-6026.
44. Kam N.W.S., Jessop T.C., Wender P.A., Dai H. Nanotube molecular transporters: internalization of carbon nanotubes-protein conjugates into mammalian cells. JAm Chem Soc 2004, 126:6850-6851.
45. Kam N.W.S., Liu Z., Dai H. Carbon nanotubes as intracellular transporters for protein and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed 2006, 45:577.
46. Kam N.W.S., O'Connell M., Wisdom J.A., Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A 2005, 102:11600-11605.
47. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klump C., Prato M., et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotubes radiotracers. Proc Natl Acad Sci U S A 2006, 103(9):3357-3362.
48. Pastorin G., Wu W., Wieckowski S., Briand J.P., Kostarelos K., Prato M., et al. Double functionalization of carbon nanotubes for multimodal drug delivery. Chem Commun 2006, 1182-1184.
49. Wu W., Wieckowski S., Pastorin G., Benincasa M., Klumpp C., Briand J.P. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl 2005, 44:6358-6362.
50. Wu Y.R., Phillips J.A., Liu H.P., Yang R.H., Tan W.H. Carbon nano-tubes protect DNA strands during cellular delivery. ACS Nano 2008, 2:2023-2028.
51. Liu Z., Tabakman S.M., Chen Z., Dai H. Preparation of carbon nanotubes bio-conjugates for biomedical applications. Nat Protoc 2009, 4:1372-1382.
52. Ali-Boucetta H., Al-Jamal K.T., McCarthy D., Prato M., Bianco A., Kostarelos K. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem Commun 2008, 8(4):459-461.
53. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., et al. Drug delivery with carbon nanotubes for invivo cancer treatment. Cancer Res 2008, 68(16):6652-6660.
54. Liu Z., Davis C., Cai W., He W., Chen X., Dai H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci U S A 2008, 105:1410-1415.
55. Huang H., Yuan Q., Shah J.S., Misra R.D.K. Anew family of folate-decorated and carbon nanotubes-mediated drug delivery system: synthesis and drug delivery response. Adv Drug Deliv Rev 2011, 63:1332-1339.
56. Kesharwani P., Ghanghoria R., Jain N.K. Carbon nanotubes exploration in cancer cell lines. Drug Discov Today 2012, 17(17-18):1023-1030.
57. Lu Y.J., Wei K.C., Ma C.C.M., Yang S.Y., Chen J.P. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Colloids Surf B Biointerfaces 2012, 89:1-9.
58. Regev O., Barenholz Y., Peretz S., Zucker D., Bavli-Felsen Y. Can carbon nanotubes-liposomes conjugates address the issues associated with carbon nanotubes in drug delivery. Future Med Chem 2013, 5(5):503-505.
59. Beg S., Rizwan M., Sheikh A.M., Hasnain M.S., Anwer K. Advancement in carbon nanotubes: basics, biomedical applications and toxicity. JPharm Pharmacol 2011, 63(2):141-163.
60. Raffa V., Ciofani G., Vittorio O., Riggio C., Cuschieri A. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine (Lond) 2010, 5(1):89-97.
61. Hirschmann T.C., Araujo P.T., Muramatsu H., Zhang X., Nielsch K., Kim Y.A., et al. Characterization of bundled and individual triple-walled carbon nanotubes by resonant Raman spectroscopy. ACS Nano 2013, 7(3):2381-2387.
62. Shen C., Brozena A.H., Wang Y.H. Double-walled carbon nanotubes: challenges and opportunities. Nanoscale 2011, 3:503-518.
63. Green A.A., Hersam M.C. Properties and application of double-walled carbon nanotubes sorted by outer-wall electronic type. ACS Nano 2011, 5(2):1459-1467.
64. [accessed 14.04.13]. http://en.wikipedia.org/wiki/Carbon_nanotube.
65. Jain A.K., Dubey V., Mehra N.K., Lodhi N., Nahar M., Mishra D.K., et al. Carbohydrate-conjugated multi walled carbon nanotubes: development and characterization. Nanomedicine 2009, 5:432-442.
66. Ji Z., Lin G., Lu Q., Meng L., Shen X., Dong L., et al. Targeted therapy of SMMC-7721 liver cancer invitro and invivo with carbon nanotubes based drug delivery system. JColloid Interface Sci 2012, 365:143-149.
67. Karousis N., Tagmatarchis N., Tasis D. Current progress on the chemical modification of carbon nanotubes. Chem Rev 2010, 110(9):5366-5397.
68. Karousis N., Kobayashi K., Shinohara H., Tagmatarchis N. Chemically induced, thermally controlled peel-off of the external walls of double-walled carbon nanotubes. Small 2010, 6(24):2826-2831.
69. Datsyuk V., Kalyuva M., Papagelis K., Parthenios J., Tasis D., Siokou A., et al. Chemical oxidation of multi walled carbon nanotubes. Carbon 2008, 46(6):833-840.
70. Allen T.M. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002, 2:750-763.
71. Agarwal A., Saraf S., Asthana A., Gupta U., Gajbhiye V., Jain N.K. Ligand based dendritic systems for tumor targeting. Int J Pharm 2008, 350:3-13.
72. McDevitt M.R., Chattopadhyay D., Kappel B.J., Jaggi J.S., Schiffman S.R., Antczak C., et al. Tumor targeting with antibody-functionalized radiolabeled carbon nanotubes. JNucl Med 2007, 48(7):1180-1189.
73. Xiao Z., Farokhzad O.C. Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. ACS Nano 2012, 6(5):3670-3676.
74. Xiao Z., Levy-Nissenbaum E., Alexis F., Luptak A., Teply B.A., Chan J.M., et al. Engineering of targeted nano-particles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano 2012, 6:696-704.
75. Wu Z., Tang L.J., Zhang X.B., Jiang J.H., Tan W. Apatmer-modified nanodrug delivery systems. ACS Nano 2011, 5(10):7696-7699.
76. Blondeau P., Rius-Ruiz F.X., Duzgun A., Riu J., Rius X. Covalent functionalization of single-walled carbon nanotubes with adenosine monophosphate: towards the synthesis of SWCNT-aptamer hybrids. Mat Sci Eng C 2011, 31:1363-1368.
77. Ellington A.D., Szostak J.W. In-vitro selection of RNA molecules that bind specifi{ligature}c ligands. Nature 1990, 346:818-822.
78. Shangguan D., Li Y., Tang Z., Cao Z.C., Chen H.W., Mall ikaratchy P., et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 2006, 103:11838-11843.
79. So H.M., Won K., Kim Y.H., Kim B.K., Ryu B.H., Na P.S., et al. Single-walled carbon nanotubes biosensors using aptamers as molecular recognition elements. JAm Chem Soc 2005, 127(34):11906-11907.
80. Mi J., Liu Y., Rabbani Z.N., Yang Z., Urban J.H., Sullenger B.A., et al. Invivo selection of tumor-targeting RNA motifs. Nat Chem Biol 2010, 6:22-24.
81. Taghdisi S.M., Lavaee P., Ramezani M., Abnous K. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes. Eur J Pharm Biopharm 2011, 77(2):200-206.
82. Das B.K., Tlili C., Badhulika S., Cella L.N., Chen W., Mulchandanai A. Single-walled carbon nanotubes chemiresistor aptasensors for small molecules: picomolar level detection of adenosine triphosphate. Chem Commun 2011, 47(13):3793-3795.
83. Fu Y., Wang T., Bu L., Xie Q., Li P., Chen J., et al. Apost-labeling strategy based on dye-induced peeling of the aptamer off single-walled carbon nanotubes for electrochemical aptasensing. Chem Commun 2011, 47(9):2637-2639.
84. 3+ complex and aptamer-wrapped carbon nanotubes. Anal Chem 2011, 83(3):782-789.
85. Lee J., Jo M., Kim T.H., Ahn J.Y., Lee D.K., Kim S., et al. Aptamer sandwich-based carbon nanotubes sensors for single-carbon atomic resolution detection of non-polar small molecular species. Lab Chip 2011, 11(1):52-56.
86. Maehashi K., Katsura T., Kerman K., Takamura Y., Matsumoto K., Tamiya E. Label-free protein biosensor based on aptamer-modified carbon nanotube field-effect transistors. Anal Chem 2007, 79(2):782-787.
87. Zelada-guillen G.A., Riu J., Duzgun A., Rius F.X. Immediate detection of living bacteria at ultralow concentrations using carbon nanotubes based potentiometric aptasensor. Angew Chem Int Ed 2009, 48(40):7334-7337.
88. Liu Z., Sun X., Nakayama-Ratchford N., Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1(1):50-56.
89. Wang L., Zhang M., Zhang N., Shi J., Zhang H., Li M., et al. Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes. Int J Nanomedicine 2011, 6:2641-2652.
90. Wang R.E., Niu Y., Wu H., Amin M.N., Cai J. Development of NGR peptide-based agents for tumor imaging. Am J Nucl Med Mol Imaging 2011, 1(1):36-46.
91. Soudy R., Ahmed S., Kaur K. NGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequences. ACS Comb Sci 2012, 14(11):590-599.
92. Chen C., Zhang H., Hou L., Shi J., Wang L., Zhang C., et al. Single-walled carbon nanotubes mediated neovasculature targeted antitumor drug delivery system. JPharm Pharm Sci 2013, 16(1):40-51.
93. Sun J.T., Hong C.Y., Pan C.Y. Surface modification of carbon nanotubes with dendrimer or hyperbranched polymers. Polym Chem 2011, 2:998-1007.
94. Zhou F., Wu S., Song S., Chen W.R., Resasco D.E., Xing D. Antitumor immunologically modified carbon nanotubes for photothermal therapy. Biomaterials 2012, 33:3235-3242.
95. Naficy S., Razal J.M., Spinks G.M., Wallace G.G. Modulated release of dexamethasone from chitosan-carbon nanotube films. Sens Actuators A Phys 2009, 155:120-124.
96. Lynam C., Moulton S.E., Wallace G.G. Carbon nanotubes biofibers. Adv Mater 2007, 19:1244-1248.
97. Razal J.M., Gilmore K.J., Wallace G.G. Carbon nanotubes biofibre formation in a polymer free coagulation bath. Adv Funct Mater 2008, 18(1):61-66.
98. Gabizon A.A. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest 2001, 19:424-436.
99. Zhang W.W. The use of gene-specific IgY antibodies for drug target discovery. Drug Discov Today 2003, 8:364-371.
100. Xiao Y., Gao X., Taratula O., Treado S., Urbas A., Holbrook R.D., et al. Anti-HER2IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells. BMC Cancer 2009, 9:351-353.
101. Erlanger B.F., Chen B.X., Zhu M., Brus L. Binding of an anti-fullerene IgG monoclonal antibody to single wall carbon nanotubes. Nano Lett 2001, 1(9):465-467.
102. Villa C.H., McDevitt M.R., Escorcia F.E., Rey D.A., Bergkvist M., Batt C.A., et al. Synthesis and biodistribution of oligonucleotide-functionalized tumor targetable carbon nanotubes. Nano Lett 2008, 8(12):4221-4228.
103. Dwyer C., Guthold M., Falvo M., Washburn S., Superfine R., Erie D. DNA-functionalized single-walled carbon nanotubes. Nanotechnology 2002, 13:601-604.
104. Iancu C., Mocan L., Bele C., Orza A.I., Tabaran F.A., Catol C., et al. Enhanced laser thermal ablation for the invitro treatment of liver cancer by specific delivery of multi walled carbon nanotubes functionalized with human serum albumin. Int J Nanomedicine 2011, 6:129-141.
105. Bhirde A.A., Patel S., Sousa A.A., Patel V., Molinolo A.A., Ji Y., et al. Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomedicine (Lond) 2010, 5(10):1535-1546.
106. Bhirde A.A., Patel V., Gavard J., Zhang G., Sousa A.A., Masedunskas A., et al. Targeted killing of cancer cells invivo and invitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009, 3(2):307-316.
107. Chen C., Xie X.X., Zhou Q., Zhang F.Y., Wang Q.L., Liu Y.Q., et al. EGF-functionalized single-walled carbon nanotubes for targeting delivery of etoposide. Nanotechnology 2012, 23:045104. 1-12.
108. Yoshimura S.H., Khan S., Ohno S., Yokogawa T., Nishikawa K., Hosoya T., et al. Site-specific attachment of a protein to a carbon nanotubes end without loss of protein function. Bioconjug Chem 2012, 23(7):1488-1493.
109. Yang K., Qin W., Tg H.L., Xie Q., Ma M., Zhang Y., et al. Polyamidoamine dendrimer-functionalized carbon nanotubes-mediated GFP gene transfection for HeLa cells: effects of different types of carbon nanotubes. JBiomed Mat Res A 2011, 99A(2):231-239.
110. 2S quantum dots immobilized on poly (amido-amine) grafted carbon nanotubes. Colloids Inter B Biointerfaces 2012, 100:215-221.
111. Qin W., Yang K., Tang H., Tan L., Xie Q., Ma M., et al. Improved GFP gene transfection mediated by polyamidomaine dendrimer-functionalized multi-walled carbon nanotubes with high biocompatibility. Colloids Surf B Biointerfaces 2011, 84:206-213.
112. McCarroll J., Baigude H., Yang C.S., Rana T.M. Nanotubes functionalized with lipids and natural amino acid dendrimers: a new strategy to create nanomaterial for delivering systemic RNAi. Bioconjug Chem 2010, 21:56-63.
113. Shi X., Wang S.H., Shen M., Antwerp M.E., Chen X., Li C., et al. Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization and invitro cancer cell targeting and imaging. Biomacromolecules 2009, 10:1744-1750.
114. Zhang Y., Qin W., Tang H., Yan F., Tan L., Xie Q., et al. Efficient assembly of multi-walled carbon nanotubes-CdSe/ZnS quantum dot hybrids with high biocompatibility and fluorescence property. Colloids Surf B Biointerfaces 2011, 87:346-352.
115. Karchemski F., Zucker D., Barenholz Y., Regev O. Carbon nanotubes-liposomes conjugate as a platform for drug delivery into cells. JControl Release 2012, 160(2):339-345.
116. Zucker D., Marcus D., Barenholz Y., Goldblum A. Liposomes drug loading efficient a working model based on loading conditions and drug's physicochemical properties. JControl Release 2009, 139(1):73-80.
117. Marc P., Paunov V.N. Assembling carbon nanotubosomes using an emulsion-inversion technique. Chem Commun 2005, 1726-1728.
118. Kumar S., Kaur I., Dharamvir K., Bhardwaj L.M. Controlling the density and site of attachment of gold nanoparticles onto the surface of carbon nanotubes. JColloid Interface Sci 2012, 369:2327.
119. Ismaili H., Labarthet F.L., Workentin M.S. Covalently assembled gold nanoparticle-carbon nanotubes hybrids via a photoinitiated carbine addition reaction. Chem Mater 2011, 23(6):1519-1525.
120. Sadek A.Z., Bansal V., McCulloch D.G., Spizzirri P.G., Latharm K., Lau D.W.M., et al. Facile, size-controlled deposition of highly dispersed gold nanoparticles on nitrogen carbon nanotubes for hydrogen sensing. Sens Actuators B Chem 2011, 160:1034-1042.
121. Torre A.L., Rance G.A., El Harfi J., Li J., Irvine D.J., Brown P.D., et al. Transport and encapsulation of gold nanoparticles in carbon nanotubes. Nanoscale 2010, 2:1006-1010.
122. Saurez-Martinez I., Bittencourt C., Ke X.X., Felten A., Pireaux J.J., Ghijsen J., et al. Probing the interaction between gold nanoparticles and oxygen functionalized carbon nanotubes. Carbon 2009, 47:1549-1554.
123. Madani S.Y., Shabani F., Dwek M.V., Seifalian A.M. Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment. Int J Nanomedicine 2013, 8:941-950.
124. Dhar S., Liu Z., Thomale J., Dai H., Lippard S.J. Targeted single-wall carbon nanotubes-mediated Pt(IV) prodrug delivery using folate as a homing device. JAm Chem Soc 2008, 130(34):11467-11476.
125. Gu Y.J., Cheng J., Jin J., Cheng S.H., Wong W.T. Development and evaluation of pH-responsive single-walled carbon nanotubes-doxorubicin complexes in cancer cells. Int J Nanomedicine 2011, 6:2889-2898.
126. Datir S.R., Das M., Singh R.P., Jain S. Hyaluronate tethered smart multi walled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjug Chem 2011, 23(11):2201-2213.
127. Heister E., Neves V., Lamprecht C., Silva S.R.P., Coley H.M., McFadden J. Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes. Carbon 2012, 50:622-632.
128. Prajapati V., Awasthi K., Gautum S., Yadav T.P., Rai M., Shrivastav O.N., et al. Targeted killing of leishmania donovani invivo and invitro with amphotericin B attached to functionalized carbon nanotubes. JAntimicrob Chemother 2011, 66:874-879.
129. Hadidi N., Kobarfard F., Nafissi-Varcheh N., Aboofazeli R. PEGylated single-walled carbon nanotubes as nanocarriers for cyclosporine A delivery. AAPS PharmSciTech 2013, 14(2):593-600. in press.
130. Terzyk A.P., Wishniewski M., Dulska L., Bielicka A., Gauden P.A., Furmaniak S., et al. Carbon nanotubes as potential material for drug delivery-experiment and simulation. Adsorption 2013, 19:269-272.
131. Vashist S.K., Zheng D., Pastorin G., Al-Rubeaan K., Luong J.H.T., Sheu F.S. Delivery of drugs and biomolecules using carbon nanotubes. Carbon 2011, 49(13):4077-4097.
132. Zhang Z., Mei L., Feng S.H. Paclitaxel drug delivery systems. Expert Opin Drug Deliv 2013, 10(3):325-340.
133. Sonia M., Cusido R.M., Mirjalili M.H., Moyano E., Palazn J., Bondill M. Production of the anticancer drug taxol in Taxus baccata suspension cultures. Process Biochem 2011, 46:23-34.
134. Sobhani Z., Dinarvand R., Atyabi F., Ghahremani M., Adeli M. Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotubes. Int J Nanomedicine 2011, 6:705-719.
135. Wu W., Li R., Bian X., Zhu Z., Ding D., Li X., et al. Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity. ACS Nano 2009, 3(9):2740-2750.
136. Jain S., Thakare V.S., Das M., Godugu C., Jain A.K., Mathur R., et al. Toxicity of multi walled carbon nanotubes with end defects critically depends on their functionalization density. Chem Res Toxicol 2011, 24(11):2028-2040.
137. Yang S.T., Luo J., Zhou Q., Wang H. Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics 2012, 2(3):271-282.
138. Cherukuri P., Gannon C.J., Leeuw T.K., Schmidt H.K., Smalley R.E., Curley S.A., et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci U S A 2006, 103:18882-18886.
139. Deng X.Y., Yang S.T., Nie H.Y., Wang H., Liu Y. Agenerally adoptable radiotracing method for tracking carbon nanotubes in animals. Nanotechnology 2008, 19:075101.
140. Prencipe G., Tabakman S.M., Welsher K., Liu Z., Goodwin A.P., Zhang L., et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. JAm Chem Soc 2009, 131:4783-4787.
141. Kaminskas L.M., McLeod V.M., Kelly B.D., Sberna G., Boyd B.J., Williamson M., et al. Acomparison of changes to doxorubicin pharmacokinetics, antitumor activity and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomedicine 2011, 8(1):103-111.
142. Liu Z., Fan A.C., Rakhra K., Sherlock S., Goodwin A., Chen X., et al. Supramolecular stacking of doxorubicin on carbon nanotubes for invivo cancer therapy. Angew Chem Int Ed 2009, 41:7668-7672.